Thomas Egebjerg

Person

Ganloese, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Highly potent ISVD compounds capable of substituting for FVIII(A)
- Patent number 12,098,400
- Issue date Sep 24, 2024
- Novo Nordisk A/S
- Andreas Vegge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-ANGPTL3 antibodies suitable for high concentration composition...
- Patent number 11,780,910
- Issue date Oct 10, 2023
- Novo Nordisk A/S
- Anette Henriksen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting tissue factor to activated platelets
- Patent number 10,106,606
- Issue date Oct 23, 2018
- Novo Nordisk A/S
- Ida Hilden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)
- Publication number 20240067944
- Publication date Feb 29, 2024
- Novo Nordisk A/S
- Andreas Vegge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPO...
- Publication number 20240043516
- Publication date Feb 8, 2024
- Novo Nordisk A/S
- Anette Henriksen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPO...
- Publication number 20230348582
- Publication date Nov 2, 2023
- Novo Nordisk A/S
- Anette Henriksen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Targeting tissue factor to activated platelets
- Publication number 20190062429
- Publication date Feb 28, 2019
- Novo Nordisk A/S
- Ida Hilden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Targeting Tissue Factor To Activated Platelets
- Publication number 20160272710
- Publication date Sep 22, 2016
- Novo Nordisk A/S
- Ida Hilden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Activatable Constructs
- Publication number 20130052192
- Publication date Feb 28, 2013
- Novo Nordisk A/S
- Jais Rose Bjelke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETING TISSUE FACTOR TO ACTIVATED PLATELETS
- Publication number 20120178908
- Publication date Jul 12, 2012
- Novo Nordisk A/S
- Ida Hilden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas Egebjerg

Person

Patents Grantslast 30 patents

Highly potent ISVD compounds capable of substituting for FVIII(A)

Anti-ANGPTL3 antibodies suitable for high concentration composition...

Targeting tissue factor to activated platelets

Patents Applicationslast 30 patents

HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)

NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPO...

NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPO...

Targeting tissue factor to activated platelets

Targeting Tissue Factor To Activated Platelets

Activatable Constructs

TARGETING TISSUE FACTOR TO ACTIVATED PLATELETS